Fenix Innovation Group
Clinical trials sponsored by Fenix Innovation Group, explained in plain language.
-
Hope for rett syndrome: cannabis oil trial aims to ease devastating symptoms
Disease control Not yet recruitingThis study is testing whether a medicinal cannabis plant extract called NTI164 can safely reduce symptoms and improve daily life for people with Rett syndrome, a rare and severe genetic disorder. About 40 female participants, aged 4 to 25, will receive either the study oil or a p…
Phase: PHASE2, PHASE3 • Sponsor: Fenix Innovation Group • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC
-
Could a cannabis extract help ease autism symptoms? major trial launches
Symptom relief Not yet recruitingThis study aims to see if a daily liquid made from medicinal cannabis (called NTI164) can help reduce the core symptoms of autism spectrum disorder (ASD) compared to a placebo. It will involve 98 children and young adults aged 6 to 25 with moderate to severe autism. Participants …
Phase: PHASE3 • Sponsor: Fenix Innovation Group • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC